Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22417253 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Multiple Sclerosis
Interventions: Drug: Laquinimod;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.